Livento Group, Inc. 8-K/A

What Happened
Livento Group, Inc. (formerly NuGene International, Inc., ticker NUGN) filed an 8-K reporting that its stockholders approved—and the Board implemented—a one-for-20,000 reverse stock split of common stock. The Certificate of Amendment was filed after the Special Meeting held May 5, 2025. FINRA announced the reverse split effective at the open of business on December 30, 2025, and OTC Markets is expected to begin trading the split-adjusted shares under the new symbol "LIVG" on January 28, 2026.

Key Details

• Reverse split ratio: 1-for-20,000 (approved May 5, 2025; corporate action effective 12/30/2025 per FINRA).
• Pre-split shares: 4,339,753,594; Post-split shares (approx.): 216,988.
• CUSIP and name changes: Current CUSIP 67052F102 noted as suspended; new CUSIP 67052F201. Company name changed to Livento Group Inc; temporary symbol NUGND, to change to LIVG after ~20 business days.
• Mechanics and rounding: No fractional shares will be issued—fractions generally rounded up to the next whole share, except equity incentive plan shares (rounded down). Transfer agent Equity Stock Transfer LLC acting as exchange agent. Registered holders need take no action; broker-held positions will be adjusted by brokers.

Why It Matters
A reverse split reduces the number of outstanding shares and increases the per‑share price on a split-adjusted basis; it does not change the company’s authorized shares, par value, or voting rights. For investors, trading liquidity and share count will change and your brokerage position should update automatically, but you should confirm how your broker handles the split and fractional-share rounding. The ticker and CUSIP changes affect how the stock is quoted and settled, so check your holdings around the OTC market effective dates.